1. Home
  2. VTYX vs LESL Comparison

VTYX vs LESL Comparison

Compare VTYX & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • LESL
  • Stock Information
  • Founded
  • VTYX 2018
  • LESL 1963
  • Country
  • VTYX United States
  • LESL United States
  • Employees
  • VTYX N/A
  • LESL N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • LESL Diversified Commercial Services
  • Sector
  • VTYX Health Care
  • LESL Miscellaneous
  • Exchange
  • VTYX Nasdaq
  • LESL Nasdaq
  • Market Cap
  • VTYX 154.9M
  • LESL 147.4M
  • IPO Year
  • VTYX 2021
  • LESL 2020
  • Fundamental
  • Price
  • VTYX $2.26
  • LESL $0.49
  • Analyst Decision
  • VTYX Buy
  • LESL Hold
  • Analyst Count
  • VTYX 4
  • LESL 11
  • Target Price
  • VTYX $11.33
  • LESL $2.32
  • AVG Volume (30 Days)
  • VTYX 2.3M
  • LESL 2.7M
  • Earning Date
  • VTYX 08-07-2025
  • LESL 08-06-2025
  • Dividend Yield
  • VTYX N/A
  • LESL N/A
  • EPS Growth
  • VTYX N/A
  • LESL N/A
  • EPS
  • VTYX N/A
  • LESL N/A
  • Revenue
  • VTYX N/A
  • LESL $1,319,859,000.00
  • Revenue This Year
  • VTYX N/A
  • LESL $1.64
  • Revenue Next Year
  • VTYX N/A
  • LESL $2.74
  • P/E Ratio
  • VTYX N/A
  • LESL N/A
  • Revenue Growth
  • VTYX N/A
  • LESL N/A
  • 52 Week Low
  • VTYX $0.78
  • LESL $0.45
  • 52 Week High
  • VTYX $3.39
  • LESL $4.51
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 56.94
  • LESL 28.98
  • Support Level
  • VTYX $2.10
  • LESL $0.45
  • Resistance Level
  • VTYX $2.42
  • LESL $0.58
  • Average True Range (ATR)
  • VTYX 0.22
  • LESL 0.06
  • MACD
  • VTYX -0.02
  • LESL -0.03
  • Stochastic Oscillator
  • VTYX 53.99
  • LESL 11.28

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About LESL Leslie's Inc.

Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.

Share on Social Networks: